Current filters:  
Life Sciences, Biotechnology & Nanotechnology
European Union
Dennemeyer Group
When the European Regulation on Supplementary Protection Certificates was first drawn up, it concerned almost exclusively the so-called "small molecules," i.e., drugs with a relatively simple structure.
Dennemeyer Group
Exclusion of biotechnological inventions from patentability – problems and solutions. In 2014, biotechnology was one of the three technological fields in which patent applications filed at the European Patent Office grew the fastest.
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Font Size:
Mondaq Social Media